SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

You and I have always thought that when

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
sentiment_stocks Member Profile
Member Level 
Followed By 57
Posts 4,745
Boards Moderated 1
Alias Born 03/29/14
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2017 5:28:13 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 5:11:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 4:18:34 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/22/2017 8:58:57 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 2:46:27 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/11/2017 2:41:35 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/21/2017 4:40:00 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/15/2017 4:12:02 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/8/2017 5:28:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 5:24:08 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/7/2017 5:19:53 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 1:14:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/26/2017 3:21:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 5:17:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/29/2017 4:27:47 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/27/2017 5:02:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2017 5:20:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/13/2017 5:08:50 PM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 6/1/2017 10:28:04 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/31/2017 7:37:55 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/26/2017 5:23:00 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 5/17/2017 11:54:01 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:35:32 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/25/2017 5:12:52 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 4/17/2017 5:26:07 PM
sentiment_stocks Member Level  Saturday, 08/12/17 02:04:54 PM
Re: flipper44 post# 129688
Post # of 139330 
You and I have always thought that when they report any results, they should take care to point out that there is also 3 months pipeline that would add 3 months to any treatment to event results.

The 11th slide in Dr. Bosch's ASCO presentation delineates and makes clear that approximate 12 week (3 month) screening process. And he referenced it several times in his presentation. So I think they realize the need to make this clear.

But what I did was simply use the hypothesized numbers that they presented in the protocol, and step by step showed at what time (based on those numbers) we might expect the 248 patients that were enrolled in the trial by February 2015 to have reached a PFS event, had they all evented.

Interestingly, it was at the same time they announced that 248 PFS events had been reached.

I'm sure that those 248 final event numbers didn't all come from the 248 patients enrolled by February 2015. There would have been some numbers coming from patients who enrolled after that. But this was based on averages, and so basing it on averages would account for that.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist